These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7616902)

  • 1. Breast cancer in NSW women: a shift in tumour size.
    Kricker A; Høyer AP; McCredie M; Porter LA
    Med J Aust; 1995 Jul; 163(2):79-81. PubMed ID: 7616902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
    Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening.
    Kricker A; Farac K; Smith D; Sweeny A; McCredie M; Armstrong BK
    Int J Cancer; 1999 Jun; 81(6):877-80. PubMed ID: 10362133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based mammography screening and breast cancer incidence in New South Wales, Australia.
    Chiu C; Morrell S; Page A; Rickard M; Brassil A; Taylor R
    Cancer Causes Control; 2006 Mar; 17(2):153-60. PubMed ID: 16425093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening.
    Taylor R; Boyages J
    J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mammography screening and sociodemographic factors on stage of female breast cancer at diagnosis in New South Wales.
    Tong S; Warner-Smith M; McGill S; Roder D; Currow D
    Aust Health Rev; 2020 Dec; 44(6):944-951. PubMed ID: 33198883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.
    Taylor R; Supramaniam R; Rickard M; Estoesta J; Moreira C
    J Med Screen; 2002; 9(1):20-5. PubMed ID: 11943793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen-detected breast cancer compared to symptomatic presentation: an analysis of surgical treatment and end-points of effective mammographic screening.
    Spillane AJ; Kennedy CW; Gillett DJ; Carmalt HL; Janu NC; Rickard MT; Donnellan MJ
    ANZ J Surg; 2001 Jul; 71(7):398-402. PubMed ID: 11450913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening and breast cancer mortality in New South Wales, Australia.
    Taylor R; Morrell S; Estoesta J; Brassil A
    Cancer Causes Control; 2004 Aug; 15(6):543-50. PubMed ID: 15280633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of screening by BreastScreen New South Wales of women with invasive breast cancer.
    Li M; Warner-Smith M; McGill S; Roder D; Currow D
    Cancer Epidemiol; 2020 Feb; 64():101659. PubMed ID: 31855779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
    Randall D; Morrell S; Taylor R; Hung WT
    Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring interval cancers in an Australian mammographic screening programme.
    Kavanagh AM; Mitchell H; Farrugia H; Giles GG
    J Med Screen; 1999; 6(3):139-43. PubMed ID: 10572844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
    van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
    Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and tumour characteristics of bilateral and unilateral interval breast cancers at screening mammography.
    van Bommel RMG; Voogd AC; Nederend J; Setz-Pels W; Louwman MWJ; Strobbe LJ; Venderink D; Tjan-Heijnen VCG; Duijm LEM
    Breast; 2018 Apr; 38():101-106. PubMed ID: 29306176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Screening, Incidence, and Mortality Across US Counties.
    Harding C; Pompei F; Burmistrov D; Welch HG; Abebe R; Wilson R
    JAMA Intern Med; 2015 Sep; 175(9):1483-9. PubMed ID: 26147578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of mammographic screening on invasive breast cancer in Western Australia.
    Jamrozik K; Byrne MJ; Dewar JM; Harvey JM; Ingram DM; Parsons RW; Watson N
    Med J Aust; 2000 Mar; 172(5):203-6. PubMed ID: 10776390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.